Peptide Reference
GHRP-6
Growth Hormone Releasing Peptide-6
A first-generation growth hormone releasing peptide that stimulates hunger and GH release. One of the earliest GHRPs developed, known for significant appetite stimulation.
Status
research
Category
growth hormone
Typical cost
$30-60/vial (5mg)
Mechanism
Binds to ghrelin receptors in the hypothalamus and pituitary, triggering GH release. Also stimulates appetite through hypothalamic feeding centers. Increases cortisol and prolactin more than newer GHRPs.
Potential benefits
- Increased growth hormone
- Significant appetite increase
- Muscle growth
- Fat loss
- Improved recovery
- Strong GH stimulation
- Rapid appetite increase
- Cost-effective
Reported side effects
- Extreme hunger
- Water retention
- Increased cortisol
- Elevated prolactin
- Injection site reactions
- Numbness/tingling
- Elevated cortisol
- Numbness
Common dosing references
subcutaneous
100-200mcg · 2-3x daily
8-12 weeks
subcutaneous
100-300mcg · 2-3x daily
8-12 weeks
Research notes
GHRP-6 growth hormone stimulation
1994
Demonstrated potent GH release but with significant appetite stimulation
GHRP-6 GH stimulation
1994
Demonstrated potent GH release with strong appetite stimulation
Regulatory and sourcing notes
Research chemical only. Not FDA-approved. Not available by prescription.
Research peptide only. Strong appetite effects make it less popular than Ipamorelin for fat loss goals.
Find peptide-aware clinics
Use location pages to compare clinics with peptide therapy signals and verify clinical oversight before treatment.
Related peptides